Evidence map›Paper›PMID 30832338›Full record

ReviewNanomaterials (Basel, Switzerland)2019

Risk Analysis of Cellulose Nanomaterials by Inhalation: Current State of Science.

James D Ede, Kimberly J Ong, Michael Goergen, Alan Rudie, Cassidy A Pomeroy-Carter, Jo Anne Shatkin

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

James D EdeVireo Advisors, LLC, Boston, MA 02130-4323, USA. jede@vireoadvisors.com.
Kimberly J OngVireo Advisors, LLC, Boston, MA 02130-4323, USA. kong@vireoadvisors.com.
Michael GoergenP3Nano, U.S. Endowment for Forestry and Communities, Greenville, SC 29601, USA. michael@usendowment.org.
Alan RudieForest Products Laboratory, USDA Forest Service, Madison, WI 53726-2398, USA. arudie@fs.fed.us.
Cassidy A Pomeroy-CarterVireo Advisors, LLC, Boston, MA 02130-4323, USA. cpomeroy@vireoadvisors.com.
Jo Anne ShatkinVireo Advisors, LLC, Boston, MA 02130-4323, USA. jashatkin@vireoadvisors.com.
Healthcentric Advisors · USForest Products Laboratory · US

Funding

P3Nano Public-Private partnership between the U.S. Endowment for Forestry and Communities, and the U.S. Department of Agriculture U.S. Forest Service Forest Products Laboratory --
6 · The paper itself

Abstract

Cellulose nanomaterials (CNs) are emerging advanced materials with many unique properties and growing commercial significance. A life-cycle risk assessment and environmental health and safety roadmap identified potential risks from inhalation of powdered CNs in the workplace as a key gap in our understanding of safety and recommended addressing this data gap to advance the safe and successful commercialization of these materials. Here, we (i) summarize the currently available published literature for its contribution to our current understanding of CN inhalation hazard and (ii) evaluate the quality of the studies for risk assessment purposes using published study evaluation tools for nanomaterials to assess the weight of evidence provided. Our analysis found that the quality of the available studies is generally inadequate for risk assessment purposes but is improving over time. There have been some advances in knowledge about the effects of short-term inhalation exposures of CN. The most recent in vivo studies suggest that short-term exposure to CNs results in transient inflammation, similarly to other poorly soluble, low toxicity dusts such as conventional cellulose, but is markedly different from fibers with known toxicity such as certain types of multiwalled carbon nanotubes or asbestos. However, several data gaps remain, and there is still a lack of understanding of the effects from long-term, low-dose exposures that represent realistic workplace conditions, essential for a quantitative assessment of potential health risk. Therefore, taking precautions when handling dry forms of CNs to avoid dust inhalation exposure is warranted.

Indexed as

celluloseinhalationnanocellulosenanomaterialreviewrisk assessmentsafety

Identifiers

PMID30832338
PMCPMC6474143
OpenAlexW2918558093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.